Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 1;78(5):578-587.
doi: 10.1001/jamaneurol.2021.0306.

Rates of Incidental Findings in Brain Magnetic Resonance Imaging in Children

Yi Li  1 Wesley K Thompson  2 Chase Reuter  2 Ryan Nillo  1 Terry Jernigan  3 Anders Dale  3 Leo P Sugrue  1 ABCD ConsortiumJulian Brown  1 Robert F Dougherty  4 Andreas Rauschecker  1 Jeffrey Rudie  1 Deanna M Barch  5 Vince Calhoun  6 Donald Hagler  7 Sean Hatton  8 Jody Tanabe  9 Andrew Marshall  10 Kenneth J Sher  11 Steven Heeringa  12 Robert Hermosillo  13 Marie T Banich  14 Lindsay Squeglia  15 James Bjork  16 Robert Zucker  17 Michael Neale  16 Megan Herting  18 Chandni Sheth  19 Rebeka Huber  19 Gloria Reeves  20 John M Hettema  21 Katia Delrahim Howlett  22 Christine Cloak  23 Arielle Baskin-Sommers  24 Kristina Rapuano  24 Raul Gonzalez  25 Nicole Karcher  26 Angela Laird  27 Fiona Baker  28 Regina James  29 Elizabeth Sowell  10 Anthony Dick  25 Samuel Hawes  25 Matthew Sutherland  25 Kara Bagot  30 Jerzy Bodurka  31 Florence Breslin  31 Amanda Morris  31 Martin Paulus  31 Kevin Gray  15 Elizabeth Hoffman  22 Susan Weiss  22 Nishadi Rajapakse  32 Meyer Glantz  33 Bonnie Nagel  34 Sarah Feldstein Ewing  34 Aimee Goldstone  28 Adolf Pfefferbaum  28 Devin Prouty  28 Monica Rosenberg  35 Susan Bookheimer  36 Susan Tapert  37 Maria Infante  37 Joanna Jacobus  37 Jay Giedd  37 Paul Shilling  37 Natasha Wade  37 Kristina Uban  38 Frank Haist  39 Charles Heyser  3 Clare Palmer  3 Joshua Kuperman  7 John Hewitt  40 Linda Cottler  41 Amal Isaiah  42 Linda Chang  43 Sarah Edwards  20 Thomas Ernst  44 Mary Heitzeg  45 Leon Puttler  45 Chandra Sripada  45 William Iacono  46 Monica Luciana  46 Duncan Clark  47 Beatriz Luna  47 Claudiu Schirda  48 John Foxe  49 Edward Freedman  49 Michael Mason  50 Erin McGlade  19 Perry Renshaw  19 Deborah Yurgelun-Todd  19 Matthew Albaugh  51 Nicholas Allgaier  51 Bader Chaarani  51 Alexandra Potter  51 Masha Ivanova  51 Krista Lisdahl  51 Elizabeth Do  52 Hermine Maes  53 Ryan Bogdan  54 Andrey Anokhin  26 Nico Dosenbach  55 Paul Glaser  26 Andrew Heath  26 Betty J Casey  24 Dylan Gee  24 Hugh P Garavan  51 Gaya Dowling  22 Sandra Brown  56
Affiliations

Rates of Incidental Findings in Brain Magnetic Resonance Imaging in Children

Yi Li et al. JAMA Neurol. .

Abstract

Importance: Incidental findings (IFs) are unexpected abnormalities discovered during imaging and can range from normal anatomic variants to findings requiring urgent medical intervention. In the case of brain magnetic resonance imaging (MRI), reliable data about the prevalence and significance of IFs in the general population are limited, making it difficult to anticipate, communicate, and manage these findings.

Objectives: To determine the overall prevalence of IFs in brain MRI in the nonclinical pediatric population as well as the rates of specific findings and findings for which clinical referral is recommended.

Design, setting, and participants: This cohort study was based on the April 2019 release of baseline data from 11 810 children aged 9 to 10 years who were enrolled and completed baseline neuroimaging in the Adolescent Brain Cognitive Development (ABCD) study, the largest US population-based longitudinal observational study of brain development and child health, between September 1, 2016, and November 15, 2018. Participants were enrolled at 21 sites across the US designed to mirror the demographic characteristics of the US population. Baseline structural MRIs were centrally reviewed for IFs by board-certified neuroradiologists and findings were described and categorized (category 1, no abnormal findings; 2, no referral recommended; 3; consider referral; and 4, consider immediate referral). Children were enrolled through a broad school-based recruitment process in which all children of eligible age at selected schools were invited to participate. Exclusion criteria were severe sensory, intellectual, medical, or neurologic disorders that would preclude or interfere with study participation. During the enrollment process, demographic data were monitored to ensure that the study met targets for sex, socioeconomic, ethnic, and racial diversity. Data were analyzed from March 15, 2018, to November 20, 2020.

Main outcomes and measures: Percentage of children with IFs in each category and prevalence of specific IFs.

Results: A total of 11 679 children (52.1% boys, mean [SD] age, 9.9 [0.62] years) had interpretable baseline structural MRI results. Of these, 2464 participants (21.1%) had IFs, including 2013 children (17.2%) assigned to category 2, 431 (3.7%) assigned to category 3, and 20 (0.2%) assigned to category 4. Overall rates of IFs did not differ significantly between singleton and twin gestations or between monozygotic and dizygotic twins, but heritability analysis showed heritability for the presence or absence of IFs (h2 = 0.260; 95% CI, 0.135-0.387).

Conclusions and relevance: Incidental findings in brain MRI and findings with potential clinical significance are both common in the general pediatric population. By assessing IFs and concurrent developmental and health measures and following these findings over the longitudinal study course, the ABCD study has the potential to determine the significance of many common IFs.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Li reported grants from the National Institutes of Health (NIH) with provided salary support during the conduct of the study and grants from the Radiologic Society for unrelated research. Dr Jernigan reported grants from National Institutes of Health during the conduct of the study. Dr Dale reported grants from National Institutes of Health Grant # U24DA041123 during the conduct of the study; in addition, Dr Dale had a patent for US7324842 licensed to Siemens Healthineers, a patent for US8107695 licensed to General Electric, a patent for US9568580B2 licensed to General Electric, and a patent for US20120280686 licensed to General Electric; and Dr Dale is a Founder of and holds equity in CorTechs Labs, Inc, and serves on its Scientific Advisory Board. He is also a member of the Scientific Advisory Board of Human Longevity Inc and receives funding through a research agreement with General Electric Healthcare. The terms of these arrangements have been reviewed and approved by the University of California, San Diego, in accordance with its conflict of interest policies. Dr Sugrue reported receiving grant U24DA041123 for the NIH during the conduct of the study. Dr Barch reported grants from National Institute of Drug Abuse and grants from National Institute of Mental Health during the conduct of the study. Dr Hagler reported a patent for EP-2141506-B1 licensed to GE HealthCare (non-exclusive royalty-free). Dr Sher's participation in the ABCD-12 USA project is funded, in part, by a consulting agreement with Washington University, grants from the NIH, various research grants, and a training grant awarded to the home institution as principal investigator or coinvestigator. Dr Heeringa reported grants from NIDA Prime: University of California, San Diego, during the conduct of the study. Dr Bjork reported grants from NIH/NIDA during the conduct of the study. Dr Zucker reported grants from NIH/NIDA during the conduct of the study. Dr Neale reported grants from NIDA Without the grant the data would not have been collected during the conduct of the study. Dr Herting reported grants from University of Southern California during the conduct of the study. Dr Reeves reported grants from NIH during the conduct of the study. Dr Cloak reported grants from National Institutes of Health during the conduct of the study; grants from National Institute of Justice outside the submitted work. Dr Gonzalez reported grants from National Institutes of Health during the conduct of the study. Dr Karcher reported grants from National Institutes of Mental Health during the conduct of the study. Dr Paulus reported personal fees from UpToDate royalties for an article about methamphetamine outside the submitted work. Dr Gray reported other from Pfizer, Inc. Consultation outside the submitted work. Dr Weiss reported other from General Electric own stock; less than $10 000 outside the submitted work. Dr Nagel reported grants from NIH during the conduct of the study. Dr Bookheimer reported grants from UCLA during the conduct of the study. Dr Hewitt reported grants from the NIH during the conduct of the study. Dr Chang reported grants from the NIH during the conduct of the study. Dr Edwards reported grants from the NIH during the conduct of the study. Dr Iacono reported grants from the NIH during the conduct of the study. Dr Luciana reported grants from the NIH during the conduct of the study. Dr Clark reported grants from the NIDA during the conduct of the study. Dr Schirda reported grants from the NIH during the conduct of the study. Dr Lisdahl reported grants from the NIH during the conduct of the study. Dr Dosenbach reported grants from NIH NS088590, MH096773, MH124567, MH122066, MH121276 during the conduct of the study; other from NOUS Imaging outside the submitted work. No other disclosures were reported.

Comment in

Similar articles

Cited by

References

    1. Dangouloff-Ros V, Roux CJ, Boulouis G, et al. . Incidental brain MRI findings in children: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 2019;40(11):1818-1823. doi:10.3174/ajnr.A6281 - DOI - PMC - PubMed
    1. Shoemaker JM, Cole C, Petree LE, et al. . Evolution of universal review and disclosure of MRI reports to research participants. Brain Behav. 2016;6(3):e00428. doi:10.1002/brb3.428 - DOI - PMC - PubMed
    1. Illes J, Chin VN. Bridging philosophical and practical implications of incidental findings in brain research. J Law Med Ethics. 2008;36(2):298-304, 212. doi:10.1111/j.1748-720X.2008.00273.x - DOI - PMC - PubMed
    1. Weiner C. Anticipate and communicate: ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts (December 2013 report of the Presidential Commission for the Study of Bioethical Issues). Am J Epidemiol. 2014;180(6):562-564. doi:10.1093/aje/kwu217 - DOI - PubMed
    1. Volkow ND, Koob GF, Croyle RT, et al. . The conception of the ABCD study: From substance use to a broad NIH collaboration. Dev Cogn Neurosci. 2018;32:4-7. doi:10.1016/j.dcn.2017.10.002 - DOI - PMC - PubMed

Publication types